These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10232387)
1. DNA levels in immune complexes circulating in mice with induced systemic lupus erythematosus. Nezlin R; Dayan M; Zinger H; Mozes E Immunol Lett; 1999 Apr; 67(2):85-90. PubMed ID: 10232387 [TBL] [Abstract][Full Text] [Related]
2. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. Nezlin R; Alarcón-Segovia D; Shoenfeld Y J Autoimmun; 1998 Oct; 11(5):489-93. PubMed ID: 9802934 [TBL] [Abstract][Full Text] [Related]
3. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175 [TBL] [Abstract][Full Text] [Related]
4. Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes. Izui S; Lambert PH; Fournié GJ; Türler H; Miescher PA J Exp Med; 1977 May; 145(5):1115-30. PubMed ID: 323400 [TBL] [Abstract][Full Text] [Related]
5. A quantitative approach to the determination of antigen in immune complexes. Nezlin R J Immunol Methods; 2000 Apr; 237(1-2):1-17. PubMed ID: 10725447 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of chromatin fragments are inversely correlated with anti-dsDNA antibody levels in human and murine systemic lupus erythematosus. Jørgensen MH; Rekvig OP; Jacobsen RS; Jacobsen S; Fenton KA Immunol Lett; 2011 Aug; 138(2):179-86. PubMed ID: 21530588 [TBL] [Abstract][Full Text] [Related]
7. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Dayan M; Zinger H; Kalush F; Mor G; Amir-Zaltzman Y; Kohen F; Sthoeger Z; Mozes E Immunology; 1997 Jan; 90(1):101-8. PubMed ID: 9038719 [TBL] [Abstract][Full Text] [Related]
8. Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation. Segal R; Dayan M; Zinger H; Mozes E Clin Exp Immunol; 1995 Jul; 101(1):66-72. PubMed ID: 7621594 [TBL] [Abstract][Full Text] [Related]
9. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Mendlovic S; Brocke S; Shoenfeld Y; Ben-Bassat M; Meshorer A; Bakimer R; Mozes E Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2260-4. PubMed ID: 3258423 [TBL] [Abstract][Full Text] [Related]
10. The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus. Sthoeger ZM; Bentwich Z; Zinger H; Mozes E J Rheumatol; 1994 Dec; 21(12):2231-8. PubMed ID: 7699622 [TBL] [Abstract][Full Text] [Related]
11. Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway. Wen Z; Xu L; Chen X; Xu W; Yin Z; Gao X; Xiong S J Immunol; 2013 Jun; 190(11):5411-22. PubMed ID: 23616573 [TBL] [Abstract][Full Text] [Related]
13. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody. Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138 [TBL] [Abstract][Full Text] [Related]
14. Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus. Dayan M; Segal R; Mozes E J Rheumatol; 1997 Jun; 24(6):1075-82. PubMed ID: 9195512 [TBL] [Abstract][Full Text] [Related]
15. Superantigens and experimental SLE induced by idiotypic dysregulation. Baharav E; Gur H; Fishman P; Ziporen L; Blank M; Aelion J; Kotb M; Shoenfeld Y Clin Exp Rheumatol; 1996; 14(4):359-66. PubMed ID: 8871833 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE. Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus. Levite M; Zinger H; Zisman E; Reisner Y; Mozes E Cell Immunol; 1995 Apr; 162(1):138-45. PubMed ID: 7704902 [TBL] [Abstract][Full Text] [Related]
18. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice. Cruse JM; Lewis RE; Dilioglou S Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362 [TBL] [Abstract][Full Text] [Related]
19. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity. Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429 [TBL] [Abstract][Full Text] [Related]
20. The role of the idiotypic network in the induction of experimental systemic lupus erythematosus. Mozes E; Brocke S; Shoenfeld Y; Mendlovic S J Cell Biochem; 1989 Jun; 40(2):173-81. PubMed ID: 2788655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]